Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitor

Related articles

1. Analysis of the effectiveness and safety of targeted therapy combined with immune checkpoint inhibitors and systemic chemotherapy in the first-line treatment of advanced biliary malignancies

   This article has 6 authors:

   1. Lu Zhao
   2. Zhengfeng Zhang
   3. Dazhen Wang
   4. Liu Yang
   5. Ze Liu
   6. Changjie Lou

2. Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors

   This article has 15 authors:

   1. Yusuke Hamakawa
   2. Ayumi Hirahara
   3. Akiko Hayashi
   4. Kota Ito
   5. Hiroyuki Shinohara
   6. Aya Shiba
   7. Yuko Higashi
   8. Masaharu Aga
   9. Kazuhito Miyazaki
   10. Yuri Taniguchi
   11. Yuki Misumi
   12. Yoko Agemi
   13. Yukiko Nakamura
   14. Tsuneo Shimokawa
   15. Hiroaki Okamoto

3. Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck

   This article has 12 authors:

   1. Aarti Bhatia
   2. Ranee Mehra
   3. Jessica Bauman
   4. Saad A. Khan
   5. Wei Wei
   6. Veronique Neumeister
   7. Teresa Sandoval-Schaefer
   8. R. Katherine Alpaugh
   9. Miriam Lango
   10. David L. Rimm
   11. John A. Ridge
   12. Barbara Burtness